一款全球首创新药的诞生,往往被寄予成为重磅炸弹的期望。
但现实并非全部如此……
近日,一家在纳斯达克上市的Biote...查看全文
牛唐2019-08-16 21:39
$Nabriva Therapeutics(NBRV)$ Lefamulin将在8月19号进行审批,药效确实还不错,但Contepo在4月30日吃了CRL,股价一直下跌,此次Lefamulin获批可能性还是较大的,不过考虑到投资人对抗生素的认可度比较低(参考$Achaogen(AKAO)$ ),市场的反应大概率应该是sell on news查看全文
苏泽逸2019-04-21 08:13
$Achaogen(AKAO)$ 抗生素研发并不是一个好的赛道,Achaogen股票已从过去52周的15美元高点跌逾98%,周二收于0.16美元,该公司估值约为1000万美元。另外三家开发创新抗生素的公司Paratek、Tetraphase市场和Nabriva股价从过去52周高点分别下跌了56%、75%和56%。查看全文
$Achaogen(AKAO)$ 美东时间 2016-04-13 10:40 Achaogen Inc at Needham Healthcare Conference 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2016-04-07 AccNo: 0001301501-16-000055 Size: 4 MBItem 7.01: Regulation FD Disclosure 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2016-04-05 AccNo: 0001301501-16-000053 Size: 25 KBItem 8.01: Other Events 网页链接
$Achaogen(AKAO)$ 内部交易: 2016-03-17,Chief Medical Officer,Friedland Ian ,卖出,1772普通股, $3.22
$Achaogen(AKAO)$ 内部交易: 2016-03-17,CEO,Hillan Kenneth J. ,卖出,3572普通股, $3.22
$Achaogen(AKAO)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2016-03-18 AccNo: 0001301501-16-000051 Size: 382 KB 网页链接
$Achaogen(AKAO)$ 8-K - Current report Filed: 2016-03-15 AccNo: 0001301501-16-000048 Size: 142 KBItem 2.02: Results of Operations and Financial Condition 网页链接
$Achaogen(AKAO)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2016-03-15 AccNo: 0001301501-16-000046 Size: 10 MB 网页链接
$Achaogen(AKAO)$ 美东时间 2016-03-15 09:00 Before Open:ACHOGEN INC Earning Release . Wall St EPS Est ($):-0.62. 网页链接
$Achaogen(AKAO)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2016-02-12 AccNo: 0001193125-16-461584 Size: 40 KB 网页链接